Search

Your search keyword '"Muñoz Torrico, Marcela"' showing total 47 results

Search Constraints

Start Over You searched for: Author "Muñoz Torrico, Marcela" Remove constraint Author: "Muñoz Torrico, Marcela"
47 results on '"Muñoz Torrico, Marcela"'

Search Results

2. Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis

4. MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network

12. Rapid Identification of Drug Resistance and Phylogeny in M. tuberculosis, Directly from Sputum Samples

14. Screening for Tuberculosis in Migrants: A Survey by the Global Tuberculosis Network

15. A bioinformatics pipeline for Mycobacterium tuberculosis sequencing that cleans contaminant reads from sputum samples

19. Expression of Surfactant protein D (SP-D) distinguishes severe pandemic influenza A(H1N1) from COVID-19

20. Additional file 1 of Anti-tuberculosis chemotherapy alters TNFR2 expression on CD4+ lymphocytes in both drug-sensitive and -resistant tuberculosis: however, only drug-resistant tuberculosis maintains a pro-inflammatory profile after a long time

21. Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019

22. Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort

23. Screening for tuberculosis in migrants: a survey by the global tuberculosis network

24. Phenotype of Peripheral NK Cells in Latent, Active, and Meningeal Tuberculosis

26. Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

27. Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020

29. Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study

30. S100A8/A9 regulates CD11b expression and neutrophil recruitment during chronic tuberculosis

31. Post-tuberculosis lung disease: a comparison of Brazilian, Italian, and Mexican cohorts.

32. MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network

33. Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

34. Fatores de risco para tuberculose: diabetes, tabagismo, álcool e uso de outras drogas

35. Risk factors for tuberculosis: diabetes, smoking, alcohol use, and the use of other drugs

36. Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond

37. Interleukin-17 limits hypoxia-inducible factor 1α and development of hypoxic granulomas during tuberculosis

38. Efecto del polimorfismo -197GA en la producción de IL-17A en respuesta a cepas hipervirulentas de M. tuberculosis

39. Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis?

40. Fatores de risco para tuberculose: diabetes, tabagismo, álcool e uso de outras drogas.

42. Clinical cases

43. Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees

45. Post-tuberculosis lung disease: a comparison of Brazilian, Italian, and Mexican cohorts.

46. Screening for Tuberculosis in Migrants: A Survey by the Global Tuberculosis Network.

47. [The response of the intensive care units during the influenza A H1N1 pandemic: the experience in Chiapas, Mexico].

Catalog

Books, media, physical & digital resources